With the arrival of gene-based therapies, biopharmaceutical companies face significant challenges in incorporating genetics expertise into programs supporting clinical trials and emerging treatments. This is especially true for therapies that target rare diseases, where physician awareness is limited and patients are difficult to identify.
Whether it is helping develop programs, facilitating genetic testing, identifying patients, engaging patients and physicians, or conducting genetic counseling, our unparalleled team of genetics experts are experienced in working with leading pharmaceutical companies and contract research organizations to develop and implement genetics-informed strategies for clinical trials and gene therapy programs.
Read this case study to learn how one innovative gene therapy company increased patient identification and recruitment efficiency, improved patient retention, and engaged physicians to successfully participate as enrollment sites.
To learn more about how we can help to incorporate genetics into your trial, study, or gene therapy program – just submit the form below and we’ll get in touch quickly.